REQUEST A DEMO
Total
USD $0.00
Search more companies

Alezapharm S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alezapharm S.A.S. Profile Updated: April 10, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Alezapharm S.A.S. is an enterprise based in Ecuador. Its main office is in Quito. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on August 31, 2021. There are currently 3 (2021) people employed by Alezapharm S.A.S.. A growth of 117.11% was recorded in its total assets.

Headquarters
Calle F Lote 65, Departamemto Bldg.
Quito; Pichincha;

Contact Details: Purchase the Alezapharm S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Alezapharm S.A.S. report to view the information.
Outstanding Shares:
Purchase the Alezapharm S.A.S. report to view the information.
Registered Capital:
Purchase the Alezapharm S.A.S. report to view the information.
Incorporation Date:
August 31, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Alezapharm S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
40.69%
Net Profit (Loss) for the Period
38.9%
Total assets
117.11%
Total equity
-2315.57%
Return on Equity (ROE)
-3694.18%
Quick Ratio
-0.33%
Cash Ratio
-0.73%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?